Stock Updates

Morning Trending Tickers: BioMarin Pharmaceutical Inc. (BMRN)

Today’s top gainers include the company BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) which is in the industry Biotechnology, gaining 0.25% today. In the last week its performance is 0.76%, and -0.60% for the past quarter. Currently, BioMarin Pharmaceutical Inc., BMRN has a target price of 112.95, so today’s gain of 0.25% is a significant step towards its target price. The GAP today is therefore 0.47%.

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), has a market cap of 15.61 B, and is based in USA. Insider ownership is at 0.40%, and institutional ownership is 100.00%.

At the current price of 89.99, it has a dividend yield of *TBA, and its target price is 112.95. This is with a profit margin of -47.40%, and total debt/equity of 0.25. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has a P/E of *TBA, as well as a forward P/E of *TBA.

With a current EPS of -3.41, and a forecasted EPS growth for next year at 53.10%,BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has had a EPS growth for the past five years at -51.20%. For the next five years EPS growth is projected to be 46.50%.

Performance for the year is 3.25%. Since its IPO date on 7/26/1999, the total performance to date is 8.63%.

Volume today for BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), is 1192983, while its average volume is 1161.47. Whilst the total gain today was 0.25%, it did have a day high of -10.47%.

Volatility for this week has been at 2.51%, and 2.81% for the month. The 52-week low for BioMarin Pharmaceutical Inc., BMRN has been 22.52%, while the 52-week-high has reached -12.20%.

Looking at its return of investments, which is -17.50%, and its return on assets is -15.10%. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has an operating margin of -62.70%. With a sales growth of 28.30% quarter over quarter. Bearing in mind that BioMarin Pharmaceutical Inc., BMRN is in the sector Healthcare, its long-term debt/equity is 0.24, and has a current ratio of 4 and 2.8 for quick ratio.

So what is the value of BioMarin Pharmaceutical Inc.? Well its PEG is *TBA, and the P/S is 13.18, along with a P/B of 5.61. Meanwhile it has a p/cash of 23.02.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Tony Dabbs

Leave a Comment